Schedule 13D ownership disclosure

Tyra Biosciences Inc

Security class unavailable · CUSIP: 90240B106

Event date: 2024-11-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,677,140
Percent of class
21.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-117861
Form type
SC 13D
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Nov 13, 2024
Reporting period
Nov 08, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub